Literature DB >> 10403910

Analysis of human C4A and C4B binding to an immune complex in serum.

B D Reilly1.   

Abstract

Previous studies using isolated complement proteins have shown that more C4A than C4B binds to certain types of immune complexes. However, the in vivo binding of the C4 isoforms to an immune complex has not been investigated in detail and may differ from events when measured with the isolated proteins. We report here the binding of C4A and C4B to an immune complex of bovine serum albumin (BSA) anti-BSA as it occurs in serum. We found that when using the isolated C4 proteins more C4A than C4B bound to the complex, but in serum similar amounts of C4A and C4B were found to bind. Furthermore, these results were not explainable by a difference in activity between isoforms. In an attempt to explain these results a number of unexpected observations were noted. First C4A, but not C4B, bound specifically to a yet unidentified 38-kD serum protein. Second, when both covalent and non-covalent binding was assessed, we found that as serum concentration increased there followed a concomitant decrease in covalent binding and C4B was more affected than C4A. The potential biological significance of these findings is discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10403910      PMCID: PMC1905463          DOI: 10.1046/j.1365-2249.1999.00940.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Polymorphism of human complement component C4.

Authors:  K T Belt; C Y Yu; M C Carroll; R R Porter
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

2.  Covalent binding and hemolytic activity of complement proteins.

Authors:  S K Law; N A Lichtenberg; R P Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

3.  Interaction between the labile binding sites of the fourth (C4) and fifth (C5) human complement proteins and erythrocyte cell membranes.

Authors:  S K Law; N A Lichtenberg; F H Holcombe; R P Levine
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

4.  Quantitative analysis of C4Ab and C4Bb binding to the C3b/C4b receptor (CR1, CD35).

Authors:  B D Reilly; C Mold
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

5.  The structural basis of the multiple forms of human complement component C4.

Authors:  K T Belt; M C Carroll; R R Porter
Journal:  Cell       Date:  1984-04       Impact factor: 41.582

6.  The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4.

Authors:  D E Isenman; J R Young
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

7.  Clinical application of a new nephelometric technique to measure complement activation.

Authors:  D Vergani; L Bevis; B A Nasaruddin; G Mieli-Vergani; D E Tee
Journal:  J Clin Pathol       Date:  1983-07       Impact factor: 3.411

8.  A molecular basis for the two locus model of human complement component C4.

Authors:  M H Roos; E Mollenhauer; P Démant; C Rittner
Journal:  Nature       Date:  1982-08-26       Impact factor: 49.962

9.  Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility.

Authors:  A H Fielder; M J Walport; J R Batchelor; R I Rynes; C M Black; I A Dodi; G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-05

10.  A comparison of the properties of two classes, C4A and C4B, of the human complement component C4.

Authors:  S K Law; A W Dodds; R R Porter
Journal:  EMBO J       Date:  1984-08       Impact factor: 11.598

View more
  2 in total

1.  A CR1 polymorphism associated with constitutive erythrocyte CR1 levels affects binding to C4b but not C3b.

Authors:  Daniel J Birmingham; Wei Chen; Grace Liang; Holly C Schmitt; Katie Gavit; Haikady N Nagaraja
Journal:  Immunology       Date:  2003-04       Impact factor: 7.397

Review 2.  Early Components of the Complement Classical Activation Pathway in Human Systemic Autoimmune Diseases.

Authors:  Katherine E Lintner; Yee Ling Wu; Yan Yang; Charles H Spencer; Georges Hauptmann; Lee A Hebert; John P Atkinson; C Yung Yu
Journal:  Front Immunol       Date:  2016-02-15       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.